Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Two Medical Sciences Division scientists have been recognised in The Blavatnik Family Foundation and the New York Academy of Sciences Blavatnik Awards for Young Scientists, the largest unrestricted cash prizes available to scientists under the age of 42.

Eleanor Stride and Timothy Behrens

Professor Behrens and Professor Stride have been recognised in The Blavatnik Family Foundation and the New York Academy of Sciences Blavatnik Awards for Young Scientists, the largest unrestricted cash prizes available to scientists under the age of 42. 

Professor Timothy Behrens, from the Nuffield Department of Clinical Neuroscience (NDCN) at the University of Oxford receives a Laureateship worth £75,000 in the Life Sciences category. He has developed innovative models for mapping the brain's electrical signals that have significant implications for brain surgery, the treatment of mental disorders, and artificial intelligence.

Professor Eleanor Stride, from the Department of Engineering Science and Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) at the University of Oxford, receives an award worth £23,000 as a Finalist. She is pioneering radical microbubble technology to develop more effective cancer treatments.

Read more about Timothy Behrens' research on the NDCN website

Read more about Eleanor Strides' research on the NDORMS website

Read the full story on University of Oxford website

Similar stories

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.